Triarco Industries Inc. 27305

September 13, 2004

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


Triarco Industries Inc.
Alphastat® Lowers DHT More Effectively Than Saw Palmetto withHigh Compliance and Cost Efficiency

WAYNE, N.J.Triarco Industrieswill announce the results of a pilot clinical trial with Alphastat®, a dietarysupplement shown to clinically reduce DHT levels. Besides inhibiting 5-alphareductase, decreasing circulating DHT levels and reducing inflammation, newevidence shows Alphastat also inhibits the aromatase enzyme. These uniqueattributes make it useful for mens and womens formulations includinghormonal balance, urinary function, sexual performance and androgenic alopecia.

The VendorWorks presentation will be given Friday, Oct. 1,from 8 to 8:50 a.m. at SupplySide West. For additional information, visitwww.triarco.com.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like